Experimental study of the influence of a neogalenical phytocomplex from the shoots of Ledum palustre on the course of acute bronchitis disease in rats
Open Access
- 31 March 2021
- journal article
- Published by OU Scientific Route in EUREKA: Health Sciences
- No. 2,p. 64-72
- https://doi.org/10.21303/2504-5679.2021.001712
Abstract
The aim of the experiment was to study the anti-inflammatory effect of the novogalene agent Ledum 50, obtained from Ledum palustre shoots, in a rat model of acute bronchitis. Materials and methods. Acute bronchitis was initiated by endotracheal administration of 1 % formalin solution. The effectiveness of Ledum 50 was investigated by the number of leukocytes and cell composition in isotonic BAL solution after 24 hours and after 8 days of the experiment. Serum levels of C-reactive protein (CRP), alkaline phosphatase (AP) and CIC were determined. Histological examination of the lungs was carried out. Results. Endotracheal injection of formalin caused irritation of the trachea and bronchi, excessive formation of bronchial secretions (heavy breathing, wheezing) in all the studied groups. The lethality of animals in the OB group on the 3rd day of the experiment (1 rat) was recorded, in the studied groups there was no death. The level of leukocytes in BAL after 24 hours exceeded the index of the IC group by 9.63 times (p<0.05), after 8 days – by 3.0 times (p<0.05). In the cellular composition of BAL, there was a significant increase in granulocytes (rod- and segmented neutrophils, eosinophils), monocytes and a decrease in the lymphocyte population against the IC group. Such changes were verified in the long term (8 days of the experiment), which indicates an inflammatory process. In the group of rats that received Ledum 50, leukocytes in the BAL significantly decreased, the number of monocytes and lymphocytes in the BAL decreased, the amount of CIC in the blood serum, CRP and AP normalized. In terms of effectiveness, Ledum 50 significantly exceeded the BAL values of the reference drug. The effectiveness of experimental therapy for acute bronchitis was also verified by studying the histostructure of the airways and the respiratory part of the lungs. Conclusions. Studies confirm the favorable course of acute bronchitis with Ledum 50 monotherapy. This fact is confirmed by the results of normalization of hematological parameters, leukocytes and BAL cell composition after 7 days of treatment with the claimed agent. This is the basis for further preclinical and clinical studies with the aim of creating an oral drug for the treatment of acute bronchitis.Keywords
This publication has 10 references indexed in Scilit:
- Efficacy of two dosing schemes of a liquid containing ivy leaves dry extract EA 575 versus placebo in the treatment of acute bronchitis in adultsERJ Open Research, 2019
- The study of the emotional and behavioral response in rats after introduction of the neogalenical phytocomplex from Ledum palustre shootsClinical pharmacy, 2019
- An update on the pharmacotherapeutic management of lower respiratory tract infectionsExpert Opinion on Pharmacotherapy, 2017
- Загальні вимоги до приготування настоянок, відварів. Дозування фітопрепаратівACTUAL INFECTOLOGY, 2016
- Herbal Medicine for Cough: a Systematic Review and Meta-AnalysisComplementary Medicine Research, 2015
- An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomised study vs. an other ivy leaves extractPhytomedicine, 2011
- Systematic Review of Clinical Trials Assessing the Effectiveness of Ivy Leaf (Hedera Helix) for Acute Upper Respiratory Tract InfectionsEvidence-Based Complementary and Alternative Medicine, 2010
- Efficacy and Tolerability of a Fluid Extract Combination of Thyme Herb and Ivy Leaves and Matched Placebo in Adults Suffering from Acute Bronchitis with Productive CoughArzneimittelforschung, 2006
- Behandlung chronischer Bronchitis mit einem Spezialextrakt aus Efeublättern – multizentrische Anwendungsbeobachtung mit 1350 PatientenComplementary Medicine Research, 2002